SOLENO THERAPEUTICS INC |
10%+ Owner |
Common Stock |
6.29M |
$297M |
$47.22 |
Aug 29, 2024 |
By Vivo Opportunity Fund Holdings, L.P. |
Terns Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
4.02M |
$24.9M |
$6.20 |
Apr 3, 2024 |
By Vivo Opportunity Fund Holdings, L.P. |
Terns Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
1.95M |
$12.1M |
$6.20 |
Apr 3, 2024 |
By: Vivo Capital Fund VIII, L.P. |
Terns Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
269K |
$1.67M |
$6.20 |
Apr 3, 2024 |
By: Vivo Capital Surplus Fund VIII, L.P. |
Sierra Oncology, Inc. |
Director, 10%+ Owner |
Common Stock |
0 |
|
$55.00 |
Jul 1, 2022 |
By: Vivo Capital Fund IX, L.P. |
Sierra Oncology, Inc. |
Director, 10%+ Owner |
Common Stock |
0 |
|
$55.00 |
Jul 1, 2022 |
By: Vivo Opportunity Fund Holdings, L.P. |
Sierra Oncology, Inc. |
Director, 10%+ Owner |
Common Stock |
0 |
|
$55.00 |
Jul 1, 2022 |
By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. |
Sierra Oncology, Inc. |
Director, 10%+ Owner |
Series A Warrants |
0 |
|
|
Jul 1, 2022 |
By: Vivo Capital Fund IX, L.P. |
Sierra Oncology, Inc. |
Director, 10%+ Owner |
Series A Warrants |
0 |
|
|
Jul 1, 2022 |
By: Vivo Opportunity Fund Holdings, L.P. |
Sierra Oncology, Inc. |
Director, 10%+ Owner |
Series A Warrants |
0 |
|
|
Jul 1, 2022 |
By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. |
SOLENO THERAPEUTICS INC |
10%+ Owner |
Tranche B Warrants (right to buy) |
0 |
|
|
Oct 2, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |